By Elsevier 01:00 pm October 18, 2017
The obstacles to personalized medicine include the high cost of precision cancer drugs, the challenge of getting patients fully engaged in their own care, a lack of mature, universal interoperability, and questions about the effectiveness of precision medicine interventions. This presentation will address these issues and discuss how to mainstream...

The Daily Brief Newsletter